Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

495.20 

1.00 0.2%

as of Dec 11 '19

52 Week Range:

298.20 499.00


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company offers a portfolio of approximately 200,000 analytical methods for evaluating the safety, identity, composition, authenticity, origin, traceability, and purity of biological substances and products, as well as for clinical diagnostic. It provides agro science, agro testing, biopharma, contract development and manufacturing organization, clinical diagnostics, consumer product testing, cosmetics testing, digital testing, electrical and electronics, environment testing, food and feed testing, forensic, genomic, industrial, materials and engineering, medical device, and REACH services. The company serves clients from a range of industries, including the pharmaceutical, food, environmental, and clinical diagnostics sectors. It operates approximately 800 laboratories in 47 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) 15.01
13.84
15.75
20.09
25.17
23.35
26.10
64.98
70.21
94.93
141.62
growth rate -7.8% 13.8% 27.6% 25.3% -7.2% 11.8% 149.0% 8.1% 35.2% 49.2%
Earnings BIT 27.53
-2.08
36.18
70.46
81.68
135.81
174.66
233.91
319.26
351.20
430.90
growth rate -100.0% 100.0% 94.8% 15.9% 66.3% 28.6% 33.9% 36.5% 10.0% 22.7%
Avg.PE 30.40
-45.40
34.25
15.95
29.41
43.48
50.85
57.50
82.02
56.54
38.08
growth rate -100.0% 100.0% -53.4% 84.4% 47.8% 17.0% 13.1% 42.6% -31.1% -32.7%
ROA 2.63
-1.61
3.35
6.12
5.90
5.44
4.69
3.13
4.44
4.35
3.44
growth rate -100.0% 100.0% 82.7% -3.6% -7.8% -13.8% -33.3% 41.9% -2.0% -20.9%
ROE 8.51
-5.49
11.10
20.50
19.11
18.94
15.15
10.82
13.46
10.65
8.76
growth rate -100.0% 100.0% 84.7% -6.8% -0.9% -20.0% -28.6% 24.4% -20.9% -17.8%
ROIC 7.10
-0.70
7.79
10.60
10.06
9.22
8.09
5.89
7.48
6.46
5.00
growth rate -100.0% 100.0% 36.1% -5.1% -8.4% -12.3% -27.2% 27.0% -13.6% -22.6%
Cur. Ratio 1.64
1.30
1.41
1.66
1.37
1.90
1.38
1.84
2.22
1.26
1.18
growth rate -20.7% 8.5% 17.7% -17.5% 38.7% -27.4% 33.3% 20.7% -43.2% -6.4%
Quick Ratio 1.48
1.12
1.25
1.48
1.27
1.75
1.25
1.65
1.96
1.09
1.02
growth rate -24.3% 11.6% 18.4% -14.2% 37.8% -28.6% 32.0% 18.8% -44.4% -6.4%
Leverage 3.45
3.35
3.27
3.41
3.09
3.86
2.85
3.86
2.54
2.39
2.70
growth rate -2.9% -2.4% 4.3% -9.4% 24.9% -26.2% 35.4% -34.2% -5.9% 13.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 129.41
119.43
174.00
245.00
276.00
316.52
364.71
513.85
605.78
826.80
1,043.32
growth rate -7.7% 45.7% 40.8% 12.7% 14.7% 15.2% 40.9% 17.9% 36.5% 26.2%
Acct.Payable 55.00
75.00
78.00
100.95
127.14
139.64
156.23
206.14
231.94
growth rate 36.4% 4.0% 29.4% 25.9% 9.8% 11.9% 32.0% 12.5%
Cur.Assets 311.98
231.65
296.00
442.00
436.00
648.98
624.40
1,425.91
1,579.41
1,826.58
1,705.40
growth rate -25.8% 27.8% 49.3% -1.4% 48.9% -3.8% 128.4% 10.8% 15.7% -6.6%
Total Assets 734.00
659.30
736.00
1,075.00
1,161.00
1,497.02
1,873.19
3,699.83
4,129.42
5,832.31
7,205.45
growth rate -10.2% 11.6% 46.1% 8.0% 28.9% 25.1% 97.5% 11.6% 41.2% 23.5%
Cash 131.70
54.40
108.00
179.00
134.00
297.26
216.62
793.76
826.10
820.36
506.25
growth rate -58.7% 98.5% 65.7% -25.1% 121.8% -27.1% 266.4% 4.1% -0.7% -38.3%
Inventory 7.65
7.77
8.00
10.00
14.00
20.14
24.62
37.52
39.55
51.81
66.37
growth rate 1.6% 3.0% 25.0% 40.0% 43.9% 22.3% 52.4% 5.4% 31.0% 28.1%
Cur.Liabilities 189.54
177.83
209.00
283.00
317.00
338.71
451.51
774.97
710.01
1,451.89
1,450.66
growth rate -6.2% 17.5% 35.4% 12.0% 6.9% 33.3% 71.6% -8.4% 104.5% -0.1%
Liabilities 514.90
462.70
505.00
754.00
789.00
1,102.28
1,208.95
2,619.52
2,372.70
3,350.33
4,483.27
growth rate -10.1% 9.1% 49.3% 4.6% 39.7% 9.7% 116.7% -9.4% 41.2% 33.8%
LT Debt 144.70
215.30
240.00
411.00
402.00
670.82
643.01
1,493.18
1,333.55
1,651.78
2,727.22
growth rate 48.8% 11.5% 71.3% -2.2% 66.9% -4.2% 132.2% -10.7% 23.9% 65.1%
Equity 219.10
203.00
230.70
320.30
372.00
387.69
656.48
957.34
1,627.48
2,443.17
2,669.19
growth rate -7.4% 13.7% 38.8% 16.1% 4.2% 69.3% 45.8% 70.0% 50.1% 9.3%
Common Shares 15.00
15.00
15.00
16.00
16.00
16.00
16.00
16.00
17.00
18.00
18.00
growth rate 0.0% 0.0% 6.7% 0.0% 0.0% 0.0% 0.0% 6.3% 5.9% 0.0%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 46.90
36.30
34.00
44.00
58.00
79.23
105.51
130.09
155.72
200.65
322.25
growth rate -22.6% -6.3% 29.4% 31.8% 36.6% 33.2% 23.3% 19.7% 28.9% 60.6%
Cash Dividends 2.60
1.40
1.40
12.00
12.10
24.60
28.59
41.07
57.94
69.48
90.97
growth rate -46.2% 0.0% 757.1% 0.8% 103.3% 16.2% 43.7% 41.1% 19.9% 30.9%
Cash From OA 60.00
64.30
85.00
110.00
134.00
169.34
212.17
291.15
371.84
405.12
543.90
growth rate 7.2% 32.2% 29.4% 21.8% 26.4% 25.3% 37.2% 27.7% 9.0% 34.3%
FCF per Share 0.35
1.22
2.96
4.00
3.96
3.94
3.01
6.78
9.03
8.57
9.72
growth rate 248.6% 142.6% 35.1% -1.0% -0.5% -23.6% 125.3% 33.2% -5.1% 13.4%
Sale Purchase of Stock 157.87
170.97
308.47
501.12
718.55
growth rate 8.3% 80.4% 62.5% 43.4%
FCF 5.00
19.00
44.00
56.00
63.00
70.00
78.00
122.00
172.00
159.00
179.00
growth rate 280.0% 131.6% 27.3% 12.5% 11.1% 11.4% 56.4% 41.0% -7.6% 12.6%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 632.80
640.10
680.00
829.00
1,044.00
1,225.57
1,410.23
1,950.07
2,536.61
2,971.42
3,781.15
growth rate 1.2% 6.2% 21.9% 25.9% 17.4% 15.1% 38.3% 30.1% 17.1% 27.3%
Op.Income 45.20
10.20
25.00
57.00
64.00
135.81
174.66
233.91
319.26
351.20
430.90
growth rate -77.4% 145.1% 128.0% 12.3% 112.2% 28.6% 33.9% 36.5% 10.0% 22.7%
IBT 27.50
-2.10
36.20
70.50
81.70
89.06
101.33
132.36
242.61
250.11
289.84
growth rate -100.0% 100.0% 94.8% 15.9% 9.0% 13.8% 30.6% 83.3% 3.1% 15.9%
Net Income 18.00
-11.30
25.00
57.00
64.00
72.18
79.10
87.32
174.00
216.77
223.94
growth rate -100.0% 100.0% 128.0% 12.3% 12.8% 9.6% 10.4% 99.3% 24.6% 3.3%
EPS 0.63
-1.36
1.03
2.79
3.40
3.32
4.93
5.37
8.16
9.97
9.58
growth rate -100.0% 100.0% 170.9% 21.9% -2.4% 48.5% 8.9% 52.0% 22.2% -3.9%
Gross Profit 381.20
389.33
99.00
147.00
174.00
204.76
260.43
360.80
479.62
556.72
719.85
growth rate 2.1% -74.6% 48.5% 18.4% 17.7% 27.2% 38.5% 32.9% 16.1% 29.3%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 92.89
122.56
122.56
97.16
97.16
growth rate 31.9% 0.0% -20.7% 0.0%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 806.34
1,043.32
1,043.32
1,001.76
1,001.76
growth rate 29.4% 0.0% -4.0% 0.0%
Acct.Payable 305.43
231.94
231.94
376.41
376.41
growth rate -24.1% 0.0% 62.3% 0.0%
Cur.Assets 1,640.57
1,705.40
1,705.40
1,565.43
1,565.43
growth rate 4.0% 0.0% -8.2% 0.0%
Total Assets 5,942.33
7,205.45
7,205.45
7,688.53
7,688.53
growth rate 21.3% 0.0% 6.7% 0.0%
Cash 558.99
506.25
506.25
304.58
304.58
growth rate -9.4% 0.0% -39.8% 0.0%
Inventory 53.20
66.37
66.37
74.42
74.42
growth rate 24.8% 0.0% 12.1% 0.0%
Cur.Liabilities 1,471.17
1,450.66
1,450.66
2,008.72
2,008.72
growth rate -1.4% 0.0% 38.5% 0.0%
Liabilities 3,389.52
4,483.27
4,483.27
4,949.00
4,949.00
growth rate 32.3% 0.0% 10.4% 0.0%
LT Debt 1,671.24
2,727.22
2,727.22
2,119.50
2,119.50
growth rate 63.2% 0.0% -22.3% 0.0%
Equity 2,514.01
2,669.19
2,669.19
2,680.60
2,680.60
growth rate 6.2% 0.0% 0.4% 0.0%
Common Shares 1.77
1.78
1.78
1.78
1.78
growth rate 0.3% 0.0% 0.2% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 75.89
85.23
85.23
70.50
70.50
growth rate 12.3% 0.0% -17.3% 0.0%
Cash Dividends 17.83
27.65
27.65
17.81
17.81
growth rate 55.0% 0.0% -35.6% 0.0%
Cash From OA 108.90
163.05
163.05
115.98
115.98
growth rate 49.7% 0.0% -28.9% 0.0%
Sale Purchase of Stock
growth rate
FCF 33.00
77.82
77.82
45.48
45.48
growth rate 135.8% 0.0% -41.6% 0.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 871.66
1,018.92
1,018.92
1,083.84
1,083.84
growth rate 16.9% 0.0% 6.4% 0.0%
Op.Income 92.89
122.56
122.56
97.16
97.16
growth rate 31.9% 0.0% -20.7% 0.0%
IBT 61.26
83.66
83.66
44.06
44.06
growth rate 36.6% 0.0% -47.3% 0.0%
Net Income 45.56
66.42
66.42
29.44
29.44
growth rate 45.8% 0.0% -55.7% 0.0%
EPS
growth rate
Gross Profit 160.18
199.75
199.75
207.44
207.44
growth rate 24.7% 0.0% 3.9% 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

A (86.94)

YOY Growth Grade:

B (74.45)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 63.30 63.30 26.09
EPS / Growth 21.0% 7.82 25.5%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 33.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 21.0% 26.8% 26.8%
Future PE 26.09 47.65 47.65
Future EPS 52.41 83.92 83.92
Value Price
MOS %
338.02
-31.7%
988.48
99.6%
988.48
99.6%
MOS Price 169.01 494.24 494.24
IRT 13.04 11.21 11.21

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.